rs3755954

Positions:

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.352C>T variant in IDUA is a synonymous (silent) variant (p.Leu118=). The highest population minor allele frequency in gnomAD v4.1.0 is 0.2517 (296774/1178988 alleles; 37458 homozygotes) in the European non-Finnish population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92642). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA145883/MONDO:0001586/091

Frequency

Genomes: 𝑓 0.22 ( 3827 hom., cov: 34)
Exomes 𝑓: 0.23 ( 40947 hom. )

Consequence

IDUA
NM_001363576.1 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign reviewed by expert panel B:16

Conservation

PhyloP100: -0.107
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IDUANM_000203.5 linkuse as main transcriptc.352C>T p.Leu118Leu synonymous_variant 3/14 ENST00000514224.2 NP_000194.2 P35475-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IDUAENST00000514224.2 linkuse as main transcriptc.352C>T p.Leu118Leu synonymous_variant 3/142 NM_000203.5 ENSP00000425081.2 P35475-1

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
33067
AN:
152108
Hom.:
3823
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.342
Gnomad AMR
AF:
0.211
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.152
Gnomad SAS
AF:
0.0661
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.198
GnomAD3 exomes
AF:
0.202
AC:
50493
AN:
250192
Hom.:
5611
AF XY:
0.195
AC XY:
26513
AN XY:
135702
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.228
Gnomad ASJ exome
AF:
0.133
Gnomad EAS exome
AF:
0.147
Gnomad SAS exome
AF:
0.0691
Gnomad FIN exome
AF:
0.242
Gnomad NFE exome
AF:
0.238
Gnomad OTH exome
AF:
0.205
GnomAD4 exome
AF:
0.231
AC:
336889
AN:
1459400
Hom.:
40947
Cov.:
34
AF XY:
0.225
AC XY:
163665
AN XY:
726026
show subpopulations
Gnomad4 AFR exome
AF:
0.189
Gnomad4 AMR exome
AF:
0.226
Gnomad4 ASJ exome
AF:
0.134
Gnomad4 EAS exome
AF:
0.128
Gnomad4 SAS exome
AF:
0.0723
Gnomad4 FIN exome
AF:
0.242
Gnomad4 NFE exome
AF:
0.252
Gnomad4 OTH exome
AF:
0.211
GnomAD4 genome
AF:
0.217
AC:
33093
AN:
152226
Hom.:
3827
Cov.:
34
AF XY:
0.213
AC XY:
15834
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.192
Gnomad4 AMR
AF:
0.211
Gnomad4 ASJ
AF:
0.135
Gnomad4 EAS
AF:
0.152
Gnomad4 SAS
AF:
0.0668
Gnomad4 FIN
AF:
0.242
Gnomad4 NFE
AF:
0.250
Gnomad4 OTH
AF:
0.196
Alfa
AF:
0.233
Hom.:
4611
Bravo
AF:
0.218
Asia WGS
AF:
0.102
AC:
357
AN:
3478
EpiCase
AF:
0.229
EpiControl
AF:
0.226

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 25, 2018- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Mucopolysaccharidosis type 1 Benign:4
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, reviewed by expert panelcurationClinGen Lysosomal Storage Disorder Variant Curation Expert PanelDec 06, 2024The NM_000203.5:c.352C>T variant in IDUA is a synonymous (silent) variant (p.Leu118=). The highest population minor allele frequency in gnomAD v4.1.0 is 0.2517 (296774/1178988 alleles; 37458 homozygotes) in the European non-Finnish population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92642). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) -
Benign, no assertion criteria providedclinical testingNatera, Inc.May 11, 2017- -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 20, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 31, 2018This variant is associated with the following publications: (PMID: 9700243, 12509712, 19396826) -
Mucopolysaccharidosis, MPS-I-H/S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Mucopolysaccharidosis, MPS-I-S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Hurler syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.2
DANN
Benign
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3755954; hg19: chr4-994452; COSMIC: COSV56102077; COSMIC: COSV56102077; API